Clinical Trials in Florida

Showing 901-920 of 12,796 trials

Open-label Extension Study of Brazikumab in Crohn's Disease

NCT03961815

The purpose of Study D5271C00002 (Legacy #3150-303-008) is to permit participants in D5271C00001 (Legacy #3150-301-008) to receive open-label brazikumab in Study D5271C00002 (Legacy #3150-303-008). This will permit long-term observation of safety in these participants with brazikumab.

Crohn's DiseaseIBD

AstraZeneca18 participantsStarted Jan 2020

Lincoln, California, United States • Clearwater, Florida, United States • Kissimmee, Florida, United States +12 more locations

COMPLETEDPhase 249 miles

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

NCT02945800

The purpose of this study is to see if nab-paclitaxel combined with gemcitabine prevents the formation or growth of tumors in participants with relapsed or refractory osteosarcoma, Ewing sarcoma, rhabdomyosarcoma and other soft tissue sarcoma and to measure the length of time during and after treatment that their disease does not get worse. Researchers also want to find out if nab-paclitaxel combined with gemcitabine is safe and tolerable.

OsteosarcomaEwing SarcomaRhabdomyosarcoma+1 more

H. Lee Moffitt Cancer Center and Research Institute59 participantsStarted Oct 2016

Birmingham, Alabama, United States • Los Angeles, California, United States • Hartford, Connecticut, United States +11 more locations

Open-label Extension Study of Brazikumab in Crohn's Disease

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Find Trials by Condition in Florida

Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

Avapritinib With Decitabine in Patients With SM-AHN

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC

A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer

A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma

A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia

Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT